GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmosa Biopharm Inc (ROCO:6875) » Definitions » Notes Receivable

Pharmosa Biopharm (ROCO:6875) Notes Receivable : NT$0.0 Mil (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Pharmosa Biopharm Notes Receivable?

Pharmosa Biopharm's Notes Receivable for the quarter that ended in Mar. 2025 was NT$0.0 Mil.


Pharmosa Biopharm Notes Receivable Historical Data

The historical data trend for Pharmosa Biopharm's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmosa Biopharm Notes Receivable Chart

Pharmosa Biopharm Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial - - - - -

Pharmosa Biopharm Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pharmosa Biopharm Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Pharmosa Biopharm Notes Receivable Related Terms

Thank you for viewing the detailed overview of Pharmosa Biopharm's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmosa Biopharm Business Description

Traded in Other Exchanges
N/A
Address
No. 508, Sec. 7, Zhongxiao E. Road, 11F / 11F-1, Nangang District, Taipei, TWN
Pharmosa Biopharm Inc is a world-class biotechnology company focusing on developing a new drug by exploiting proprietary formulation and manufacturing technology. Geographically, the company generates almost all of its revenue from the USA, and a small portion from Taiwan.

Pharmosa Biopharm Headlines

No Headlines